-
Allogene Therapeutics, Inc. (NASDAQ:ALLO) Given Average Rating of "Moderate Buy" by Analysts
ソース: Buzz FX / 18 12 2024 02:51:11 America/New_York
Allogene Therapeutics, Inc. (NASDAQ:ALLO) Given Average Rating of "Moderate Buy" by Analysts Written by MarketBeat December 18, 2024 Share Link copied to clipboard. Allogene Therapeutics, Inc. ( NASDAQ:ALLO - Get Free Report ) has been give
Read more...